Ticker,Title,Link
SNSE,"Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Sensei Biotherapeutics (SNSE) and Annovis Bio (ANVS)",8/7/2024 10:44:36 AM
SNSE,SNSE Stock Earnings: Sensei Biotherapeutics Beats EPS for Q2 2024,8/6/2024 5:53:19 PM
SNSE,"Analysts Are Bullish on These Healthcare Stocks: Sensei Biotherapeutics (SNSE), Viking Therapeutics (VKTX)",6/3/2024 6:30:21 PM
SNSE,Sensei Biotherapeutics to Participate in Jefferies Global Healthcare Conference,5/30/2024 1:30:00 PM
SNSE,Sensei stock plunges 46% in wake of Phase 1 data,5/24/2024 5:42:55 PM
SNSE,Sensei Biotherapeutics Presents Promising Clinical Data from Phase 1 Dose Escalation Study of SNS-101,5/23/2024 11:10:00 PM
SNSE,"CureVac, Oragenics, IGM Biosciences among healthcare movers",5/22/2024 2:00:31 PM
SNSE,Buy Rating Justified for Sensei Biotherapeutics Amidst Strong Pipeline and Financial Stability,5/13/2024 8:36:00 PM
SNSE,Sensei Biotherapeutics Poised for Growth: A Strong Buy Rating Amid Financial Stability and Promising Clinical Trials,5/10/2024 10:26:26 AM
SNSE,SNSE Stock Earnings: Sensei Biotherapeutics Misses EPS for Q1 2024,5/9/2024 5:54:49 PM
SNSE,"CTMX, HSDT and SNSE are among premarket gainers",5/3/2024 12:29:21 PM
SNSE,"JAGX, SNSE and BON among mid-day movers",5/2/2024 4:49:49 PM
SNSE,Sensei Biotherapeutics to Present Topline Clinical Data from the SNS-101 Phase I Dose Escalation Study at the 2024 ASCO Annual Meeting,4/24/2024 10:05:00 PM
SNSE,Sensei Biotherapeutics to Participate in Canaccord Genuity’s Horizons in Oncology Virtual Conference,4/9/2024 1:30:00 PM
SNSE,Sensei Biotherapeutics Announces Nature Communications Publication Describing Mechanism of Action of SNS-101 Selectively Targeting the Active Form of VISTA within the Tumor Microenvironment,4/4/2024 10:05:00 PM
SNSE,Analysts Offer Insights on Healthcare Companies: Axsome Therapeutics (AXSM) and Sensei Biotherapeutics (SNSE),3/26/2024 1:20:21 AM
SNSE,Sensei Biotherapeutics to Participate in the 3rd Annual VISTA Symposium,3/22/2024 12:30:00 PM
SNSE,Sensei Biotherapeutics to Present New Preclinical Data at Upcoming Scientific Conferences,3/6/2024 1:30:00 PM
SNSE,Sensei Biotherapeutics (SNSE) Gets a Buy from Oppenheimer,2/29/2024 1:07:31 PM
SNSE,Sensei Biotherapeutics reports FY results,2/28/2024 7:19:50 PM
SNSE,"Sensei Biotherapeutics Streamlines Board, Appoints Interim Chair",2/9/2024 9:56:36 AM
SNSE,Sensei Biotherapeutics to Present at Upcoming Conferences,2/7/2024 1:30:00 PM
SNSE,Buy Rating Affirmed for Sensei Biotherapeutics Amidst Promising SNS-101 Clinical Progress and Favorable Safety Data,1/5/2024 11:28:49 AM
SNSE,Sensei Biotherapeutics Provides Corporate Update and Highlights Key Upcoming Milestones,1/4/2024 1:30:00 PM
SNSE,"Analysts Offer Insights on Healthcare Companies: Korro Bio (KRRO), Praxis Precision Medicines (PRAX) and Sensei Biotherapeutics (SNSE)",12/4/2023 11:20:14 AM
SNSE,"Analysts Are Bullish on These Healthcare Stocks: Sensei Biotherapeutics (SNSE), Akebia Therapeutics (AKBA)",11/17/2023 11:31:47 AM
SNSE,Sensei Biotherapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights,11/7/2023 1:30:00 PM
SNSE,Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday,11/6/2023 12:28:22 PM
SNSE,Sensei Biotherapeutics Reports Favorable Clinical Data for SNS-101 at 2023 SITC Annual Meeting,11/3/2023 9:05:00 PM
SNSE,"Sensei Biotherapeutics Appoints Stephanie Krebs, MS, MBA, as Chief Business Officer",11/1/2023 12:30:00 PM
SNSE,Sensei Biotherapeutics to Present Initial Clinical Data from Dose Escalation Trial of SNS-101 at 2023 SITC Annual Meeting,10/25/2023 3:05:00 PM
SNSE,Sensei Biotherapeutics Presents Trial-in-Progress Poster for Phase 1/2 Clinical Study of SNS-101 at ESMO 2023,10/23/2023 1:30:00 PM
SNSE,Sensei Biotherapeutics Announces Initiation of Combination Arm for Phase 1/2 Clinical Study of SNS-101 with Regeneron’s Libtayo®,9/27/2023 1:30:00 PM
SNSE,"Sensei Biotherapeutics Presents New Preclinical Data Reinforcing SNS-101 Pharmacokinetic Profile, Safety Characteristics and Mechanism of Action at the Seventh CRI-ENCI-AACR International Cancer...",9/21/2023 1:30:00 PM
SNSE,"Sensei Biotherapeutics to Present New Preclinical Data Supporting Mechanism of Action, Pharmacokinetic Profile and Safety Characteristics for SNS-101, a Conditionally Active VISTA-blocking...",9/13/2023 1:30:00 PM
SNSE,Sensei Biotherapeutics to Participate in Upcoming Investor Conferences ,8/30/2023 1:30:00 PM
SNSE,Citi Sticks to Their Buy Rating for Sensei Biotherapeutics (SNSE),8/4/2023 12:15:41 PM
SNSE,Sensei Biotherapeutics GAAP EPS of -$0.31,8/3/2023 2:21:20 PM
SNSE,Citigroup Remains a Buy on Sensei Biotherapeutics (SNSE),5/10/2023 11:25:37 PM
SNSE,Sensei Biotherapeutics GAAP EPS of -$0.33 beats by $0.02,5/9/2023 12:52:05 PM
SNSE,"FENG, ALXO and GFAI among mid-day gainers",4/21/2023 5:53:45 PM
SNSE,Sensei gains FDA IND clearance for solid tumors candidate,4/20/2023 12:18:28 PM
SNSE,"Premier cancer research event, AACR is starting this week; Here is what to expect",4/9/2023 4:00:00 PM
SNSE,Sensei Biotherapeutics GAAP EPS of -$1.58 beats by $0.01,3/28/2023 11:52:51 AM
SNSE,Sensei in agreement with National Cancer Institute for solid tumors candidate,2/6/2023 3:41:27 PM
SNSE,Sensei Biotherapeutics Enters Clinical Supply Agreement With Regeneron For Libtayo ,1/5/2023 2:23:10 PM
SNSE,"Sensei to shut Boston research site, cut workforce by ~40%",12/8/2022 4:06:53 PM
SNSE,Sensei Biotherapeutics to Participate in the Piper Sandler 34th Annual Healthcare Conference,11/22/2022 1:30:00 PM
SNSE,"Sensei Biotherapeutics Announces Collaboration with Washington University, St. Louis to Support Development of SNS-101, a Conditionally Active VISTA-blocking Antibody",11/21/2022 1:30:00 PM
SNSE,Sensei Biotherapeutics Presents Preclinical Data at the 37th Society for Immunotherapy of Cancer (SITC) Annual Meeting,11/10/2022 3:00:00 PM
SNSE,Berenberg Bank Remains a Hold on Sensei Biotherapeutics (SNSE),11/9/2022 11:05:44 AM
SNSE,Sensei Biotherapeutics GAAP EPS of -$0.44 misses by $0.09,11/8/2022 2:19:02 PM
SNSE,"Sensei Biotherapeutics to Host Virtual Key Opinion Leader Webinar, “Lessons from VISTA: New Strategies to Address an Important Immune Checkpoint”",11/7/2022 1:30:00 PM
SNSE,Sensei Biotherapeutics to Participate in the 13th Annual Jefferies Global Healthcare Conference,11/2/2022 12:30:00 PM
SNSE,Sensei Biotherapeutics (SNSE) Receives a Hold from Berenberg Bank,10/11/2022 8:15:52 AM
SNSE,Sensei Biotherapeutics to Present New Preclinical Data at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting,10/5/2022 2:05:00 PM
SNSE,"Benzinga's Top Ratings Upgrades, Downgrades For October 3, 2022",10/3/2022 4:15:40 PM
SNSE,"Sensei Biotherapeutics Presents Preclinical Data for SNS-101, a Conditionally Active VISTA-blocking Antibody, at the Sixth Annual CRI-ENCI-AACR International Cancer Immunotherapy Conference:",9/30/2022 10:05:00 PM
SNSE,"Sensei Biotherapeutics to Present Preclinical Data for SNS-101, a Conditionally Active VISTA-blocking Antibody, at the Sixth Annual CRI-ENCI-AACR International Cancer Immunotherapy Conference:",9/21/2022 10:05:00 PM
SNSE,"Sensei: Preclinical Data Shows Favorable Pharmacokinetic, Immunologic Effects Of SNS-101 ",8/31/2022 2:17:32 PM
SNSE,Sensei Biotherapeutics to Participate in Upcoming Investor Conferences,8/23/2022 1:30:00 PM
SNSE,Sensei Biotherapeutics Reports Second Quarter 2022 Financial Results and Recent Business Highlights,8/9/2022 1:30:00 PM
SNSE,"Sensei Biotherapeutics Appoints Patrick Gallagher, MBA, MPH, as Chief Business Officer",6/1/2022 1:30:00 PM
SNSE,Sensei Biotherapeutics to Participate in Jefferies Healthcare Conference,5/25/2022 1:30:00 PM
SNSE,Sensei Biotherapeutics Reports First Quarter 2022 Financial Results and Recent Business Highlights,5/10/2022 1:30:00 PM
SNSE,Sensei Biotherapeutics Reports Full Year 2021 Financial Results and Business Highlights,3/10/2022 1:30:00 PM
SNSE,"Sensei Biotherapeutics Appoints William Ringo, MBA, as Chair of Board of Directors",3/9/2022 10:05:00 PM
SNSE,Sensei Biotherapeutics to Participate in the 32nd Annual Oppenheimer Healthcare Conference,3/3/2022 1:30:00 PM
SNSE,Executives Buy Around $1M Of 5 Penny Stocks,2/25/2022 1:39:45 PM
SNSE,Sensei Biotherapeutics to Participate in Citi’s 2022 Virtual Immuno-Oncology Summit,2/11/2022 1:30:00 PM
SNSE,Sensei Biotherapeutics names Erin Colgan as CFO,1/6/2022 2:14:05 PM
SNSE,63 Biggest Movers From Yesterday,12/31/2021 9:35:01 AM
SNSE,44 Stocks Moving In Thursday's Mid-Day Session,12/30/2021 8:03:03 PM
SNSE,Sensei Biotherapeutics Named a Winner of Comparably’s Best CEO Award,12/16/2021 3:01:00 PM
SNSE,"The Daily Biotech Pulse: Mesoblast, Novartis Sever COVID-19 Treatment Partnerships, Sigilon To Reduce Workforce, ASH Presentations Move Stocks",12/14/2021 2:22:02 PM
SNSE,Sensei Biotherapeutics Announces Addition to the Nasdaq Biotechnology Index,12/13/2021 10:01:00 PM
SNSE,Sensei Biotherapeutics to Participate in the Piper Sandler 33rd Annual Healthcare Conference,11/19/2021 10:02:00 PM
SNSE,"Sensei Biotherapeutics Presents Preclinical Data for SNS-101, a pH-Selective Anti-VISTA Antibody, at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting",11/12/2021 1:02:00 PM
SNSE,Sensei Biotherapeutics Reports Third Quarter 2021 Results and Recent Business Highlights,11/9/2021 2:54:48 PM
SNSE,"Sensei Biotherapeutics to Participate in the Berenberg Virtual U.S. CEO Conference on Tuesday, November 9, 2021",11/3/2021 2:01:00 PM
SNSE,"Sensei Biotherapeutics to Present New Preclinical Data for SNS-101, a Proprietary Anti-VISTA Antibody, at the 36th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)",10/1/2021 2:05:00 PM
SNSE,60 Biggest Movers From Yesterday,8/25/2021 10:50:10 AM
SNSE,22 Stocks Moving in Wednesday's Pre-Market Session,8/11/2021 1:02:58 PM
SNSE,Sensei Biotherapeutics Appoints Kristian Humer to its Board of Directors,8/2/2021 2:01:00 PM
SNSE,"The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs",7/15/2021 2:07:56 PM
SNSE,"The Daily Biotech Pulse: ScPharma's Positive Data, Lilly Goes Shopping, LeMaitre Pre-Announces Q2 Revenues",7/14/2021 1:48:12 PM
SNSE,"The Daily Biotech Pulse: Lilly, Morphic's Positive Data At ECCO, Humanigen's COVID Treatment Gets Expedited Review In UK, TransCode IPO",7/9/2021 1:36:16 PM
SNSE,"The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test",7/8/2021 1:45:17 PM
SNSE,"The Daily Biotech Pulse: Opiant Spikes On Data, OncoSec Rallies On Merck Collaboration, XBiotech Special Dividend",7/7/2021 1:41:27 PM
SNSE,"Benzinga's Top Ratings Upgrades, Downgrades For July 1, 2021",7/1/2021 4:11:05 PM
SNSE,"The Daily Biotech Pulse: COVID Disappointments For Altimmune And Angion, Brickell Jumps On Hyperhidrosis Study Updates, 2 IPOs",6/30/2021 1:28:56 PM
SNSE,35 Stocks Moving In Tuesday's Mid-Day Session,6/29/2021 6:08:52 PM
SNSE,"Sensei Biotherapeutics Announces Prioritization of Next-Generation Multi-Antigenic ImmunoPhage Platform, Monoclonal Antibody and Nanobody Programs",6/28/2021 10:05:00 PM
SNSE,"The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes",5/31/2021 5:06:35 PM
SNSE,"Annovis Bio, Gracell Biotechnologies leads healthcare gainers; Precipio, Cullinan Oncology among major losers",5/21/2021 3:02:53 PM
SNSE,38 Stocks Moving In Thursday's Mid-Day Session,5/20/2021 6:09:40 PM
SNSE,Sensei Biotherapeutics Announces New Clinical Data from the Ongoing Phase 1/2 Combination Trial of SNS-301 in Patients with Squamous Cell Carcinoma of the Head and Neck,5/19/2021 11:03:00 PM
SNSE,"The Daily Biotech Pulse: Spero Secures NIAID Funding, GlaxoSmithKline Releases COVID-19 Data, BioNTech Gets New CFO",5/18/2021 1:44:45 PM
SNSE,"The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts",5/14/2021 1:59:10 PM
SNSE,"The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use",5/13/2021 2:10:52 PM
SNSE,"The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron",5/12/2021 2:57:17 PM
SNSE,"The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings",5/11/2021 1:54:31 PM
SNSE,"The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs",5/7/2021 1:40:08 PM
SNSE,"Sensei Biotherapeutics Appoints Maura Gillison, M.D., Ph.D., and Richard Ulevitch, Ph.D., to its Immuno-Oncology Advisory Board",5/5/2021 2:05:00 PM
SNSE,"Sensei Biotherapeutics Appoints Jessie M. English, Ph.D. to its Board of Directors",4/5/2021 2:00:00 PM
SNSE,71 Biggest Movers From Yesterday,4/1/2021 11:06:58 AM
SNSE,"The Daily Biotech Pulse: Pfizer Vaccine 100% Effective In Adolescents, Equillium Readout, Amgen Goes Shopping, Achilles IPO",3/31/2021 1:41:12 PM
SNSE,"The Daily Biotech Pulse: Wave Life Sciences Pulls Plug On 2 Assets, Amarin's Vascepa Snags European Approval, Biocept Jumps On Earnings",3/30/2021 2:06:26 PM
SNSE,Sensei Biotherapeutics EPS of -$12.53,3/25/2021 1:10:23 PM
SNSE,Sensei Biotherapeutics Announces Inclusion in Russell 2000 Index,3/22/2021 1:00:00 PM
SNSE,7 Stocks With Significant Insider Buying,3/9/2021 9:07:45 PM
SNSE,"SNSE, AGLE, CRWD and ISEE among after-hours movers",3/5/2021 10:55:19 PM
SNSE,"The Daily Biotech Pulse: FDA Nod For Pfizer, Kiniksa Rises On Commercialization Pact With Regeneron, Bio-Techne To Buy Diagnostic Company",3/4/2021 2:12:10 PM
SNSE,"Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2021",3/1/2021 4:14:41 PM
SNSE,"The Week Ahead In Biotech (Feb. 28-March 6): KemPharm, Gilead FDA Decisions and More Earnings",2/27/2021 5:58:02 PM
SNSE,"The Daily Biotech Pulse: Adcom Test Awaits J&J's COVID-19 Vaccine, Lilly To Supply Additional Antibody Therapy Doses To US, Regulatory Setback For Tricida",2/26/2021 2:16:52 PM
SNSE,"The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts",2/11/2021 1:26:22 PM
SNSE,Sensei Biotherapeutics Announces Closing of Initial Public Offering,2/10/2021 10:55:31 PM
SNSE,101 Biggest Movers From Friday,2/8/2021 11:16:27 AM
SNSE,66 Stocks Moving In Friday's Mid-Day Session,2/5/2021 6:03:19 PM
